AIP
AGIO icon

Ameritas Investment Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Ameritas Investment Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199K Buy
5,368
+649
+14% +$19.7K 0.01% 1400
2026
Q1 		$160K Hold
4,719
– – ﹤0.01% 1408
2025
Q4 		$128K Hold
4,719
– – ﹤0.01% 1545
2025
Q3 		$189K Sell
4,719
-1,194
-20% -$44.9K 0.01% 1273
2025
Q2 		$197K Hold
5,913
– – 0.01% 1310
2025
Q1 		$173K Hold
5,913
– – 0.01% 1353
2024
Q4 		$194K Buy
5,913
+394
+7% +$18.5K 0.01% 1342
2024
Q3 		$245K Hold
5,519
– – 0.01% 1186
2024
Q2 		$238K Hold
5,519
– – 0.01% 1154
2024
Q1 		$161K Hold
5,519
– – 0.01% 1438
2023
Q4 		$123K Hold
5,519
– – ﹤0.01% 1597
2023
Q3 		$137K Buy
5,519
+932
+20% +$24.7K 0.01% 1434
2023
Q2 		$130K Buy
4,587
+387
+9% +$9.63K ﹤0.01% 1413
2023
Q1 		$96.5K Hold
4,200
– – ﹤0.01% 1558
2022
Q4 		$121K Hold
4,200
– – ﹤0.01% 1463
2022
Q3 		$118K Hold
4,200
– – 0.01% 1374
2022
Q2 		$93K Hold
4,200
– – ﹤0.01% 1558
2022
Q1 		$122K Hold
4,200
– – ﹤0.01% 1501
2021
Q4 		$138K Sell
4,200
-321
-7% -$12.9K ﹤0.01% 1487
2021
Q3 		$209K Sell
4,521
-309
-6% -$14.9K 0.01% 1173
2021
Q2 		$266K Buy
+4,830
New +$270K 0.01% 1048

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Ameritas Investment Partners's AGIO Position: Q2 2026 in Review

Ameritas Investment Partners increased its Agios Pharmaceuticals (AGIO) stake by 14% in Q2 2026, buying an estimated $19.7K and bringing the position to 5,368 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #1400.

Ameritas Investment Partners first reported a position in AGIO in Q2 2021 and has held it in 21 quarters since. The position peaked at $266K in Q2 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Ameritas Investment Partners held 5,368 shares of Agios Pharmaceuticals worth $199K as of Q2 2026.
  • Ameritas Investment Partners bought 649 Agios Pharmaceuticals shares in Q2 2026, an estimated $19.7K.
  • Agios Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1400 holding.
  • Ameritas Investment Partners first reported a position in Agios Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Ameritas Investment Partners's Agios Pharmaceuticals position peaked at $266K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.